Details
Stereochemistry | ACHIRAL |
Molecular Formula | 2Cl.Ra |
Molecular Weight | 293.924 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].[Cl-].[223Ra++]
InChI
InChIKey=RWRDJVNMSZYMDV-SIUYXFDKSA-L
InChI=1S/2ClH.Ra/h2*1H;/q;;+2/p-2/i;;1-3
DescriptionCurator's Comment: description was created based on several sources, including
http://www.ncbi.nlm.nih.gov/pubmed/?term=23653243; http://www.ncbi.nlm.nih.gov/pubmed/?term=23977665
Curator's Comment: description was created based on several sources, including
http://www.ncbi.nlm.nih.gov/pubmed/?term=23653243; http://www.ncbi.nlm.nih.gov/pubmed/?term=23977665
Radium Ra 223 dichloride is a radiotherapeutic drug that is approved for the treatment of male patients with symptoms of advanced prostate cancer with bone metastases. Ra 223 mimics calcium and forms complexes with the bone mineral hydroxyapatite at areas of increased bone turnover. The radioactive alpha particles emitted by radium Ra 223 helps in killing cancer cells in the bone by damaging their DNA. Radium Ra 223 causes minimal damage to the nearby healthy cells.
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | XOFIGO Approved UseXofigo is an alpha particle-emitting radioactive thera peutic agent indicated for the treatment of patients with castration-resistant prostate cancer, symptoma tic bone metastases and no known visceral metastatic disease Launch Date2013 |
Sample Use Guides
The dose regimen is 50 kBq (1.35 microcurie) per kg body weight, given at 4 week intervals for 6 injections.
Route of Administration:
Intravenous
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C129819
Created by
admin on Fri Dec 15 17:25:31 GMT 2023 , Edited by admin on Fri Dec 15 17:25:31 GMT 2023
|
||
|
EMA ASSESSMENT REPORTS |
XOFIGO (AUTHORIZED: PROSTATIC NEOPLASMS)
Created by
admin on Fri Dec 15 17:25:31 GMT 2023 , Edited by admin on Fri Dec 15 17:25:31 GMT 2023
|
||
|
WHO-VATC |
QV10XX03
Created by
admin on Fri Dec 15 17:25:31 GMT 2023 , Edited by admin on Fri Dec 15 17:25:31 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID80893194
Created by
admin on Fri Dec 15 17:25:31 GMT 2023 , Edited by admin on Fri Dec 15 17:25:31 GMT 2023
|
PRIMARY | |||
|
4800
Created by
admin on Fri Dec 15 17:25:31 GMT 2023 , Edited by admin on Fri Dec 15 17:25:31 GMT 2023
|
PRIMARY | |||
|
SUB129907
Created by
admin on Fri Dec 15 17:25:31 GMT 2023 , Edited by admin on Fri Dec 15 17:25:31 GMT 2023
|
PRIMARY | |||
|
Radium Ra 223 Dichloride
Created by
admin on Fri Dec 15 17:25:31 GMT 2023 , Edited by admin on Fri Dec 15 17:25:31 GMT 2023
|
PRIMARY | |||
|
RADIUM-223 CHLORIDE
Created by
admin on Fri Dec 15 17:25:31 GMT 2023 , Edited by admin on Fri Dec 15 17:25:31 GMT 2023
|
PRIMARY | |||
|
RJ00KV3VTG
Created by
admin on Fri Dec 15 17:25:31 GMT 2023 , Edited by admin on Fri Dec 15 17:25:31 GMT 2023
|
PRIMARY | |||
|
RJ00KV3VTG
Created by
admin on Fri Dec 15 17:25:31 GMT 2023 , Edited by admin on Fri Dec 15 17:25:31 GMT 2023
|
PRIMARY | |||
|
444811-40-9
Created by
admin on Fri Dec 15 17:25:31 GMT 2023 , Edited by admin on Fri Dec 15 17:25:31 GMT 2023
|
PRIMARY | |||
|
ZZ-73
Created by
admin on Fri Dec 15 17:25:31 GMT 2023 , Edited by admin on Fri Dec 15 17:25:31 GMT 2023
|
PRIMARY | |||
|
1424174
Created by
admin on Fri Dec 15 17:25:31 GMT 2023 , Edited by admin on Fri Dec 15 17:25:31 GMT 2023
|
PRIMARY | RxNorm | ||
|
C62535
Created by
admin on Fri Dec 15 17:25:31 GMT 2023 , Edited by admin on Fri Dec 15 17:25:31 GMT 2023
|
PRIMARY | |||
|
DB08913
Created by
admin on Fri Dec 15 17:25:31 GMT 2023 , Edited by admin on Fri Dec 15 17:25:31 GMT 2023
|
PRIMARY | |||
|
m9481
Created by
admin on Fri Dec 15 17:25:31 GMT 2023 , Edited by admin on Fri Dec 15 17:25:31 GMT 2023
|
PRIMARY | Merck Index | ||
|
CHEMBL2111187
Created by
admin on Fri Dec 15 17:25:31 GMT 2023 , Edited by admin on Fri Dec 15 17:25:31 GMT 2023
|
PRIMARY | |||
|
100000155897
Created by
admin on Fri Dec 15 17:25:31 GMT 2023 , Edited by admin on Fri Dec 15 17:25:31 GMT 2023
|
PRIMARY | |||
|
74895
Created by
admin on Fri Dec 15 17:25:31 GMT 2023 , Edited by admin on Fri Dec 15 17:25:31 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD